Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Magnesium Sulphate (500mg/ml) Injection
Therapeutic Category
Antispasmodic, Neurology
Dosage Form
Injection
Packaging Type
Ampule
Packaging
10x2ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Megsum Injection containing Magnesium Sulphate is used for the management of electrolyte imbalance and critical care conditions. It helps in stabilizing nerve and muscle function and is commonly used in conditions like eclampsia and severe deficiencies.
Magnesium Sulphate works by regulating neuromuscular transmission and maintaining electrolyte balance in the body. This action helps in preventing seizures and supporting normal physiological functions.
The injection is widely used in hospitals, especially in emergency and obstetric care settings, ensuring continuous demand and regular usage across multiple departments.
With its essential role in emergency medicine and high usage in hospital care, this product offers strong business potential for distributors and stockists. Its consistent institutional demand, critical care importance, and frequent usage make it a reliable product for steady sales and growth in the hospital segment.
Some patients may experience flushing, sweating, nausea, or a feeling of warmth. Excessive levels may lead to low blood pressure, respiratory depression, reduced reflexes, or cardiac disturbances, which require immediate medical attention.
Megsum Injection is indicated for the management of eclampsia and pre-eclampsia to prevent and control seizures in pregnant women. It is also used in hypomagnesemia, certain cardiac arrhythmias, and severe asthma exacerbations. It helps stabilize nerve activity, prevent convulsions, and restore electrolyte balance.
This injection should be administered under strict medical supervision, usually in a hospital setting. Continuous monitoring of reflexes, respiratory function, and serum magnesium levels is essential to avoid toxicity. Use with caution in patients with kidney impairment.
Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.
Composition : Acetylcysteine (20% w/v) Injection
Composition : Ketorolac (30mg) Injection
Composition : Thiocolchicoside (4mg) Injection
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg) Tablet
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
Composition : Aceclofenac (100mg) + Thiocolchicoside (4mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (8mg) Tablet
Composition : Aceclofenac (200mg) + Pregabalin (75mg) Tablet
Composition : Cefoperazone (1000mg) + Sulbactam (500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Magwave Injection, containing Magnesium Sulphate 50% w/v, has strong demand in gynecology, emergency care, and hospital critical care segments, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable and hospital-use portfolios.
Medical distributors and agencies can benefit from the consistent hospital demand for magnesium sulphate injections used in conditions like eclampsia, seizures, severe hypomagnesemia, and emergency obstetric care. Magwave Injection helps strengthen a comprehensive critical care and gynecology emergency product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Magwave Injection with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted emergency and gynecology injectable product range when partnering for Magwave Injection distribution.
Medical distributors, stockists, and wholesalers interested in Magwave Injection can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.